Rating History for 4D Molecular Therapeutics (FDMT) by B.Riley

More Stocks Rated by B.Riley | Latest Ratings for FDMT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/31/2026 Mayank Mamtani New Coverage Buy
(N/A)		 37.00
(N/A)		 9.61
(14.35)		 49.32% Details